Efficacy information influences intention to take COVID-19 vaccine. / Davis, Colin; Golding, Matt; McKay, Ryan.

In: British Journal of Health Psychology, Vol. 27, 08.04.2022, p. 300–319.

Research output: Contribution to journalArticlepeer-review

Published

Standard

Efficacy information influences intention to take COVID-19 vaccine. / Davis, Colin; Golding, Matt; McKay, Ryan.

In: British Journal of Health Psychology, Vol. 27, 08.04.2022, p. 300–319.

Research output: Contribution to journalArticlepeer-review

Harvard

Davis, C, Golding, M & McKay, R 2022, 'Efficacy information influences intention to take COVID-19 vaccine', British Journal of Health Psychology, vol. 27, pp. 300–319. https://doi.org/10.1111/bjhp.12546

APA

Davis, C., Golding, M., & McKay, R. (2022). Efficacy information influences intention to take COVID-19 vaccine. British Journal of Health Psychology, 27, 300–319. https://doi.org/10.1111/bjhp.12546

Vancouver

Davis C, Golding M, McKay R. Efficacy information influences intention to take COVID-19 vaccine. British Journal of Health Psychology. 2022 Apr 8;27:300–319. https://doi.org/10.1111/bjhp.12546

Author

Davis, Colin ; Golding, Matt ; McKay, Ryan. / Efficacy information influences intention to take COVID-19 vaccine. In: British Journal of Health Psychology. 2022 ; Vol. 27. pp. 300–319.

BibTeX

@article{f103908949d540cdbfd49882cb5f5109,
title = "Efficacy information influences intention to take COVID-19 vaccine",
abstract = "ObjectivesA successful response to the COVID-19 pandemic requires achievinghigh levels of vaccine uptake. We tested whether directly contrasting the highefficacy of COVID-19 vaccines with the lower efficacy of the annual flu vaccinewould increase intentions to take a COVID-19 vaccine.DesignA pre-registered online study of 481 participants compared fourinformation conditions: a) No Information, b) COVID-19 Vaccine InformationOnly, and COVID-19 Vaccine Information combined with Flu Vaccine Informationsuggesting either c) 60% efficacy or d) 40% efficacy; we measured COVID-19 andflu vaccine intentions along with several other vaccine-related variables.MethodsThe Prolific platform was used to recruit 481 UK participants (64%female; aged between 18 and 85 years) who had been pre-screened to haveintermediate levels of vaccine hesitancy. After reading a short text (~200words) about COVID-19 vaccines participants were asked about their vaccinationintentions.Results Providing information about thesafety and efficacy of the new COVID-19 vaccines resulted in vaccinationintentions that were significantly higher than those in the No Informationcondition; providing the same COVID vaccine efficacy information in the contextof information about flu vaccine efficacy resulted in a further significantincrease in vaccination intentions. This positive contrast effect for theCOVID-19 vaccine was not associated with reduced flu vaccine intentions. ConclusionsVaccination intentions can be strengthened through a simplemessaging intervention that utilises context effects to increase perceivedresponse efficacy. @font-face{font-family:{"}Cambria Math{"};panose-1:2 4 5 3 5 4 6 3 2 4;mso-font-charset:0;mso-generic-font-family:roman;mso-font-pitch:variable;mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face{font-family:Calibri;panose-1:2 15 5 2 2 2 4 3 2 4;mso-font-alt:Calibri;mso-font-charset:0;mso-generic-font-family:swiss;mso-font-pitch:variable;mso-font-signature:-536859905 -1073732485 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal{mso-style-unhide:no;mso-style-qformat:yes;mso-style-parent:{"}{"};margin:0cm;mso-pagination:widow-orphan;font-size:12.0pt;font-family:{"}Calibri{"},sans-serif;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:{"}Times New Roman{"};mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;}p.MsoBodyText, li.MsoBodyText, div.MsoBodyText{mso-style-unhide:no;mso-style-qformat:yes;mso-style-link:{"}Body Text Char{"};margin-top:9.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-indent:34.0pt;line-height:200%;mso-pagination:widow-orphan;font-size:12.0pt;font-family:{"}Times New Roman{"},serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:{"}Times New Roman{"};mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language:EN-US;}span.BodyTextChar{mso-style-name:{"}Body Text Char{"};mso-style-unhide:no;mso-style-locked:yes;mso-style-link:{"}Body Text{"};font-family:{"}Times New Roman{"},serif;mso-ascii-font-family:{"}Times New Roman{"};mso-hansi-font-family:{"}Times New Roman{"};mso-ansi-language:EN-US;}p.FirstParagraph, li.FirstParagraph, div.FirstParagraph{mso-style-name:{"}First Paragraph{"};mso-style-unhide:no;mso-style-qformat:yes;mso-style-parent:{"}Body Text{"};mso-style-next:{"}Body Text{"};margin-top:9.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-indent:34.0pt;line-height:200%;mso-pagination:widow-orphan;font-size:12.0pt;font-family:{"}Times New Roman{"},serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:{"}Times New Roman{"};mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language:EN-US;}.MsoChpDefault{mso-style-type:export-only;mso-default-props:yes;font-family:{"}Calibri{"},sans-serif;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:{"}Times New Roman{"};mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;}div.WordSection1{page:WordSection1;}",
author = "Colin Davis and Matt Golding and Ryan McKay",
year = "2022",
month = apr,
day = "8",
doi = "10.1111/bjhp.12546",
language = "English",
volume = "27",
pages = "300–319",
journal = "British Journal of Health Psychology",
issn = "1359-107X",
publisher = "Wiley-Blackwell",

}

RIS

TY - JOUR

T1 - Efficacy information influences intention to take COVID-19 vaccine

AU - Davis, Colin

AU - Golding, Matt

AU - McKay, Ryan

PY - 2022/4/8

Y1 - 2022/4/8

N2 - ObjectivesA successful response to the COVID-19 pandemic requires achievinghigh levels of vaccine uptake. We tested whether directly contrasting the highefficacy of COVID-19 vaccines with the lower efficacy of the annual flu vaccinewould increase intentions to take a COVID-19 vaccine.DesignA pre-registered online study of 481 participants compared fourinformation conditions: a) No Information, b) COVID-19 Vaccine InformationOnly, and COVID-19 Vaccine Information combined with Flu Vaccine Informationsuggesting either c) 60% efficacy or d) 40% efficacy; we measured COVID-19 andflu vaccine intentions along with several other vaccine-related variables.MethodsThe Prolific platform was used to recruit 481 UK participants (64%female; aged between 18 and 85 years) who had been pre-screened to haveintermediate levels of vaccine hesitancy. After reading a short text (~200words) about COVID-19 vaccines participants were asked about their vaccinationintentions.Results Providing information about thesafety and efficacy of the new COVID-19 vaccines resulted in vaccinationintentions that were significantly higher than those in the No Informationcondition; providing the same COVID vaccine efficacy information in the contextof information about flu vaccine efficacy resulted in a further significantincrease in vaccination intentions. This positive contrast effect for theCOVID-19 vaccine was not associated with reduced flu vaccine intentions. ConclusionsVaccination intentions can be strengthened through a simplemessaging intervention that utilises context effects to increase perceivedresponse efficacy. @font-face{font-family:"Cambria Math";panose-1:2 4 5 3 5 4 6 3 2 4;mso-font-charset:0;mso-generic-font-family:roman;mso-font-pitch:variable;mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face{font-family:Calibri;panose-1:2 15 5 2 2 2 4 3 2 4;mso-font-alt:Calibri;mso-font-charset:0;mso-generic-font-family:swiss;mso-font-pitch:variable;mso-font-signature:-536859905 -1073732485 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal{mso-style-unhide:no;mso-style-qformat:yes;mso-style-parent:"";margin:0cm;mso-pagination:widow-orphan;font-size:12.0pt;font-family:"Calibri",sans-serif;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;}p.MsoBodyText, li.MsoBodyText, div.MsoBodyText{mso-style-unhide:no;mso-style-qformat:yes;mso-style-link:"Body Text Char";margin-top:9.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-indent:34.0pt;line-height:200%;mso-pagination:widow-orphan;font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language:EN-US;}span.BodyTextChar{mso-style-name:"Body Text Char";mso-style-unhide:no;mso-style-locked:yes;mso-style-link:"Body Text";font-family:"Times New Roman",serif;mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Roman";mso-ansi-language:EN-US;}p.FirstParagraph, li.FirstParagraph, div.FirstParagraph{mso-style-name:"First Paragraph";mso-style-unhide:no;mso-style-qformat:yes;mso-style-parent:"Body Text";mso-style-next:"Body Text";margin-top:9.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-indent:34.0pt;line-height:200%;mso-pagination:widow-orphan;font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language:EN-US;}.MsoChpDefault{mso-style-type:export-only;mso-default-props:yes;font-family:"Calibri",sans-serif;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;}div.WordSection1{page:WordSection1;}

AB - ObjectivesA successful response to the COVID-19 pandemic requires achievinghigh levels of vaccine uptake. We tested whether directly contrasting the highefficacy of COVID-19 vaccines with the lower efficacy of the annual flu vaccinewould increase intentions to take a COVID-19 vaccine.DesignA pre-registered online study of 481 participants compared fourinformation conditions: a) No Information, b) COVID-19 Vaccine InformationOnly, and COVID-19 Vaccine Information combined with Flu Vaccine Informationsuggesting either c) 60% efficacy or d) 40% efficacy; we measured COVID-19 andflu vaccine intentions along with several other vaccine-related variables.MethodsThe Prolific platform was used to recruit 481 UK participants (64%female; aged between 18 and 85 years) who had been pre-screened to haveintermediate levels of vaccine hesitancy. After reading a short text (~200words) about COVID-19 vaccines participants were asked about their vaccinationintentions.Results Providing information about thesafety and efficacy of the new COVID-19 vaccines resulted in vaccinationintentions that were significantly higher than those in the No Informationcondition; providing the same COVID vaccine efficacy information in the contextof information about flu vaccine efficacy resulted in a further significantincrease in vaccination intentions. This positive contrast effect for theCOVID-19 vaccine was not associated with reduced flu vaccine intentions. ConclusionsVaccination intentions can be strengthened through a simplemessaging intervention that utilises context effects to increase perceivedresponse efficacy. @font-face{font-family:"Cambria Math";panose-1:2 4 5 3 5 4 6 3 2 4;mso-font-charset:0;mso-generic-font-family:roman;mso-font-pitch:variable;mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face{font-family:Calibri;panose-1:2 15 5 2 2 2 4 3 2 4;mso-font-alt:Calibri;mso-font-charset:0;mso-generic-font-family:swiss;mso-font-pitch:variable;mso-font-signature:-536859905 -1073732485 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal{mso-style-unhide:no;mso-style-qformat:yes;mso-style-parent:"";margin:0cm;mso-pagination:widow-orphan;font-size:12.0pt;font-family:"Calibri",sans-serif;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;}p.MsoBodyText, li.MsoBodyText, div.MsoBodyText{mso-style-unhide:no;mso-style-qformat:yes;mso-style-link:"Body Text Char";margin-top:9.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-indent:34.0pt;line-height:200%;mso-pagination:widow-orphan;font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language:EN-US;}span.BodyTextChar{mso-style-name:"Body Text Char";mso-style-unhide:no;mso-style-locked:yes;mso-style-link:"Body Text";font-family:"Times New Roman",serif;mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Roman";mso-ansi-language:EN-US;}p.FirstParagraph, li.FirstParagraph, div.FirstParagraph{mso-style-name:"First Paragraph";mso-style-unhide:no;mso-style-qformat:yes;mso-style-parent:"Body Text";mso-style-next:"Body Text";margin-top:9.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm;text-indent:34.0pt;line-height:200%;mso-pagination:widow-orphan;font-size:12.0pt;font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language:EN-US;}.MsoChpDefault{mso-style-type:export-only;mso-default-props:yes;font-family:"Calibri",sans-serif;mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi;mso-fareast-language:EN-US;}div.WordSection1{page:WordSection1;}

U2 - 10.1111/bjhp.12546

DO - 10.1111/bjhp.12546

M3 - Article

VL - 27

SP - 300

EP - 319

JO - British Journal of Health Psychology

JF - British Journal of Health Psychology

SN - 1359-107X

ER -